Research libraryMOLEKUL / SOURCE RECORD

Treatment of asthenic disorders in patients with psychoautonomic syndrome: results of a multicenter study on efficacy and safety of ladasten]

Authors not yet confirmed · 2010 · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 110(5 Suppl 1):17-26. PMID 20559263

Uncontrolled human reportEnglish abstractSource linked
This is Molekul’s research summary, not the original publication. Educational information only, not medical advice. Seek qualified healthcare help for medical conditions.

What does this source report?

Reports symptom and quality-of-life improvements during 28 days of Ladasten treatment and follow-up. The abstract reports adverse events in 3% and discontinuation in 0.8%.

Population and setting
728 analyzable patients with psychoautonomic syndrome in 28 Russian centers
Evidence type
Uncontrolled human report
Preparation
See the original report; formulation details require verification.
Source language
Russian
Title provenance
Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.

What are the limitations?

  • No concurrent comparator is described in the abstract; improvement alone does not establish causality.
  • PMID 21322821 has the same title, cohort and abstract: treat it as a related report of this cohort, not independent replication.
  • Short follow-up and incomplete ascertainment cannot rule out uncommon or long-term harms.

Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.

Source access and review scope

Indexed citation and abstract checked through Europe PMC / PubMed. Original methods and risk of bias not fully appraised.

Recorded source-check date: 2026-09-29. This date does not imply a completed systematic review.

Open original source or index record ↗

Cite and trace this record

Original source: Author unconfirmed. Treatment of asthenic disorders in patients with psychoautonomic syndrome: results of a multicenter study on efficacy and safety of ladasten] Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 110(5 Suppl 1):17-26. PMID 20559263 2010.

Molekul research summary: https://molekul.io/research/acto-20559263. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.

Bibliography entry

Related compound profiles

Editorial policy and evidence standards